Multiple foci of invasive breast cancer: can breast MRI influence surgical management? L. JohnsonS. PinderM. Douek Review 16 April 2011 Pages: 1 - 5
Signaling mechanism of cell adhesion molecules in breast cancer metastasis: potential therapeutic targets Dong-Mei LiYu-Mei Feng Review 16 April 2011 Pages: 7 - 21
Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes Marcel SmidMarlous HoesJohn W. M. Martens Preclinical study 15 July 2010 Pages: 23 - 30
Amplification of the prolactin receptor gene in mammary lobular neoplasia Danh Tran-ThanhNona C. ArnesonSusan J. Done Preclinical study 24 July 2010 Pages: 31 - 40
High-resolution analyses of gene copy number reveal new insights into the prognosis and progression of breast cancers Alejandro GruD. Craig Allred Invited Commentary 04 September 2010 Pages: 41 - 43
Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers Peter KabosJames M. HaughianCarol A. Sartorius Preclinical study 28 July 2010 Pages: 45 - 55
Cacalol, a natural sesquiterpene, induces apoptosis in breast cancer cells by modulating Akt-SREBP-FAS signaling pathway Wen LiuEiji FurutaKounosuke Watabe Preclinical study 28 July 2010 Pages: 57 - 68
Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivo Yi ChenEdwin A. AlvarezJoyce M. Slingerland Preclinical study 29 July 2010 Pages: 69 - 78
Prevalence of the variant allele rs61764370 T>G in the 3′UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families Antoinette HollestelleCory PelletierJoanne B. Weidhaas Preclinical study 30 July 2010 Pages: 79 - 84
Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients Laura C. HautalaDario GrecoHeli Nevanlinna Preclinical study 30 July 2010 Pages: 85 - 95
PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells Ensaf M. Al-HujailyAmeera Gaafar MohamedAbdelilah Aboussekhra Preclinical study 01 August 2010 Pages: 97 - 107
Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells Lev M. BersteinWei YueRichard J. Santen Preclinical study 04 August 2010 Pages: 109 - 117
Monitoring of neoadjuvant chemotherapy using multiparametric, 23Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer Michael A. JacobsRonald OuwerkerkVered Stearns Clinical Trial 01 April 2011 Pages: 119 - 126
Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer M. MartinA. RomeroC. M. Perou Clinical Trial 05 April 2011 Pages: 127 - 136
Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients Bjørnar GiljeOddmund NordgårdJan P. A. Baak Clinical Trial 08 April 2011 Pages: 137 - 146
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study Manuela CampiglioRosaria BufalinoElda Tagliabue Clinical Trial 11 April 2011 Pages: 147 - 154
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology George SomloSean K. LauRichard H. Bruce Clinical trial 16 April 2011 Pages: 155 - 163
Value of post-operative reassessment of estrogen receptor α expression following neoadjuvant chemotherapy with or without gefitinib for estrogen receptor negative breast cancer Mogens BernsdorfEva BalslevBent Ejlertsen Clinical trial 23 April 2011 Pages: 165 - 170
Clinical features and course of brain metastases in triple-negative breast cancer: comparison with human epidermal growth factor receptor 2-positive and other type at single institution in Korea Geundoo JangSung Sook LeeSung-Bae Kim Clinical trial 26 April 2011 Pages: 171 - 177
A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicing Mads ThomassenInge Søkilde PedersenTorben A. Kruse Epidemiology 24 December 2010 Pages: 179 - 185
Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994–1998 and 2003–2006 Guillaume GalySana Intidhar Labidi-GalyBertrand Favier Epidemiology 24 December 2010 Pages: 187 - 195
Investigating Hardy–Weinberg equilibrium in case–control or cohort studies or meta-analysis Andreas ZieglerKristel Van SteenStefan Wellek Epidemiology 24 December 2010 Pages: 197 - 201
The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis Jun WangBaocheng WangJianshi Di Epidemiology 25 December 2010 Pages: 203 - 209
BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast–ovarian cancer families. Identification of novel mutations and unclassified variants L. DelgadoG. FernándezI. M. Muse Epidemiology 29 December 2010 Pages: 211 - 218
Traditional-Westernizing continuum of change in screening behaviors: comparison between Arab women in Israel and the West Bank Faisal AzaizaMiri CohenMriam Awad Epidemiology 30 December 2010 Pages: 219 - 227
Post-diagnosis dietary factors and survival after invasive breast cancer Jeannette M. BeasleyPolly A. NewcombWalter C. Willett Epidemiology 01 January 2011 Pages: 229 - 236
Trends in return to work of breast cancer survivors C. A. M. RoelenP. C. KoopmansU. Bültmann Epidemiology 01 January 2011 Pages: 237 - 242
Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer Rulla M. TamimiGraham A. ColditzStuart J. Schnitt Epidemiology 01 January 2011 Pages: 243 - 250
Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province Yongdong JiangJiguang HanDa Pang Epidemiology 01 January 2011 Pages: 251 - 257
Age of diagnosis, tumor size, and survival after breast cancer: implications for mammographic screening Steven A. Narod Epidemiology 04 January 2011 Pages: 259 - 266
Replication of genome-wide discovered breast cancer risk loci in the Cypriot population Maria A. LoizidouAndreas HadjisavvasKyriacos Kyriacou Epidemiology 06 January 2011 Pages: 267 - 272
High estrogen receptor expression in early breast cancer: chemotherapy needed to improve RFS? A. C. RegiererR. WoltersR. Kreienberg Epidemiology 06 January 2011 Pages: 273 - 281
Combining accurate genetic and clinical information in breast cancer risk model Ke-Da YuQi FangZhi-Ming Shao Letter to the Editor 12 February 2011 Pages: 283 - 285
Return to work after treatment for breast cancer Luigi CavannaMassimo AmbroggiMichela Monfredo Letter to the Editor 16 February 2011 Pages: 287 - 288
The association between two polymorphisms in the TYMS gene and breast cancer risk: appraisal of a recent meta-analysis Yan-Feng ZouFang WangXiao-Liang Feng Letter to the Editor 15 February 2011 Pages: 289 - 290
NBS1 8360G > C polymorphism is associated with breast cancer risk was not credible: appraisal of a recent meta-analysis Feng WangShuzhi ZhaoHuanlong Qin Letter to the Editor 15 February 2011 Pages: 291 - 292
Are polymorphisms of the ataxia telangiectasia mutated gene associated with breast cancer risk? Bo JinFusheng JiangZhishan Ding Letter to the Editor 16 February 2011 Pages: 293 - 295
Is RAD51 135G>C polymorphism really associated with breast cancer in general population? Biased design and results lead to inappropriate conclusion Ke-Da YuBin LiZhi-Ming Shao Letter to the Editor 18 February 2011 Pages: 297 - 300
